Mechanisms of dental pulp stem cell differentiation into functional endothelium
牙髓干细胞分化为功能性内皮细胞的机制
基本信息
- 批准号:9897411
- 负责人:
- 金额:$ 37.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:ANGPT1 geneAddressAnastomosis - actionAngiopoietinsBloodBlood VesselsBlood capillariesCell CommunicationCell Differentiation processCell TherapyCellsDataDental PulpDevelopmentEmbryoEmbryonic DevelopmentEndothelial CellsEndotheliumEventExhibitsExperimental ModelsFundingGenerationsGoalsHematopoietic stem cellsHumanImaging TechniquesIn VitroInvestmentsMaintenanceMesenchymal DifferentiationMesenchymal Stem CellsMetabolicModelingMolecularMusNatural regenerationNutrientOdontoblastsOrganOutcomeOxygenParacrine CommunicationPathway interactionsPatientsPericytesPlayProcessProto-Oncogene Protein c-kitReceptor Protein-Tyrosine KinasesResearch DesignRoleSignal PathwaySignal TransductionSmooth Muscle MyocytesStem Cell FactorStem cell transplantStructureTestingTherapeuticTissue EngineeringTissuesTooth structureUndifferentiatedUp-RegulationVascular Endothelial CellVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth FactorsVascularizationWorkbasebeta catenincadherin 5clinical translationclinically significantdesignexperienceexperimental studyin vivointercellular communicationpostnatalreceptorreconstitutionrecruitregenerativeself-renewalstem cell biologystem cell differentiationstem cellstissue regenerationtissue repairtoolvasculogenesis
项目摘要
PROJECT SUMMARY/ABSTRACT
The Problem: Human dental pulps contain mesenchymal stem cells (MSC), i.e. dental pulp stem cells (DPSC)
that orchestrate tooth development and tissue regeneration. In the 1st funding cycle, we showed that DPSC are
capable of differentiating into endothelial cells that form functional blood vessels. These findings suggest that
pluripotent DPSC can differentiate into tissue-forming cells (e.g. odontoblasts) while exhibiting the capacity to
generate blood vessels to support the metabolic demands of tissue regeneration. However, the mechanisms
employed by DPSC to generate blood vessels are unclear, and therefore our ability to exploit the differentiation
potential of these cells in therapeutic tissue regeneration is limited. Hypothesis: We have shown that signaling
initiated by vascular endothelial growth factor (VEGF) through its receptor VEGFR1, and by the canonical
Wnt/B-catenin pathway, regulate the endothelial differentiation of DPSC. In preliminary studies, we made the
exciting observation that DPSC-derived blood vessels anastomize with the host vasculature and become
invested by smooth muscle cells/pericytes. However, the mechanisms regulating these events are not known.
VE-Cadherin plays a key role in endothelial cell orientation, blood vessel organization and anastomosis during
embryonic development. Once blood vessels are formed, the Angiopoietin/Tie2 pathway regulates vessel
maturation. Here, we will determine if these signaling pathways play a role in the anastomosis and maturation
of post-natal stem cell-derived blood vessels, using dental pulp stem cells as experimental models of MSC.
Furthermore, it has been postulated that the long-term viability and function of tissues regenerated with MSC
depends on the ability of these cells to reconstitute and maintain stem cell niches. Preliminary data suggest
that endothelial cell-derived factors induce self-renewal of DPSC, as demonstrated by Bmi-1 upregulation and
secondary sphere formation. Here, we will explore the role of the Stem Cell Factor (SCF)/c-Kit axis on the
maintenance of stem cells in DPSC-regenerated tissues. Our working hypothesis is: “Blood vessels generated
by endothelial differentiation of dental pulp stem cells anastomize with the host vasculature, mature upon mural
cell investment, and maintain a pool of stem cells”. To test this hypothesis, we propose the following specific
aims: S.A.#1: To define the role of VE-Cadherin on the anastomosis of DPSC-derived blood vessels; S.A.#2:
To define the function of Angiopoietin signaling on the maturation of DPSC-derived blood vessels; S.A.#3: To
define the role of the SCF/c-Kit pathway in the maintenance of stem cells in DPSC-generated tissues.
Significance: The clinical translation of stem cell-based therapies requires the understanding of mechanisms
that control the differentiation fate of these cells. Successful completion of this project will lead to mechanism-
based therapies that exploit the vasculogenic potential of mesenchymal stem cells in tissue regeneration. The
development of safe strategies that enable efficient vascularization of tissues generated upon transplantation
of stem cells will benefit a large number of patients that require therapeutic tissue regeneration.
项目总结/摘要
问题:人类牙髓含有间充质干细胞(MSC),即牙髓干细胞(DPSC)
协调牙齿发育和组织再生。在第一个融资周期中,我们表明DPSC是
能够分化成形成功能性血管的内皮细胞。这些发现表明
多能DPSC可以分化成组织形成细胞(例如成牙本质细胞),同时表现出
生成血管以支持组织再生的代谢需求。然而,机制
DPSC用于产生血管的能力尚不清楚,因此我们利用DPSC分化血管的能力尚不清楚。
这些细胞在治疗性组织再生中的潜力有限。假设:我们已经证明,
由血管内皮生长因子(VEGF)通过其受体VEGFR 1启动,
Wnt/B-catenin通路,调节DPSC的内皮分化。在初步研究中,我们
令人兴奋的观察是DPSC衍生的血管与宿主脉管系统融合,
由平滑肌细胞/周细胞包埋。然而,调节这些事件的机制尚不清楚。
VE-钙粘蛋白在内皮细胞定向、血管组织化和血管吻合中起关键作用。
胚胎发育一旦血管形成,血管生成素/Tie 2途径调节血管生成,
成熟在这里,我们将确定这些信号通路是否在吻合和成熟中发挥作用。
以牙髓干细胞作为MSC的实验模型,研究了新生儿干细胞来源的血管。
此外,已经假设用MSC再生的组织的长期存活力和功能
取决于这些细胞重建和维持干细胞小生境的能力。初步数据表明
内皮细胞衍生因子诱导DPSC自我更新,如Bmi-1上调所示,
次级球体形成。在这里,我们将探讨干细胞因子(SCF)/c-Kit轴在细胞凋亡中的作用。
维持DPSC再生组织中的干细胞。我们的工作假设是:“血管生成
牙髓干细胞通过内皮分化与宿主血管系统融合,在壁周成熟,
细胞投资,并维持干细胞库”。为了验证这一假设,我们提出了以下具体的
目标:S.A.# 1:确定VE-钙粘蛋白在DPSC衍生血管吻合中的作用; S.A.#第二章:
定义血管生成素信号传导对DPSC衍生的血管成熟的功能; S.A.# 3:向
确定SCF/c-Kit途径在DPSC产生的组织中维持干细胞的作用。
意义:基于干细胞的治疗的临床转化需要了解机制
控制着这些细胞的分化命运该项目的成功完成将导致机制-
在组织再生中利用间充质干细胞的血管生成潜力的基于治疗的方法。的
开发能够使移植后产生的组织有效血管化的安全策略
干细胞的应用将使大量需要治疗性组织再生的患者受益。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacques Eduardo Nor其他文献
Jacques Eduardo Nor的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacques Eduardo Nor', 18)}}的其他基金
Metronomic Small Molecule Inhibitor of Bcl2 in Head and Neck Cancer Therapy
Bcl2 节律小分子抑制剂在头颈癌治疗中的应用
- 批准号:
8729053 - 财政年份:2013
- 资助金额:
$ 37.05万 - 项目类别:
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car
MDM2/Bcl-2 在腺样囊肿临床前模型中的治疗性抑制
- 批准号:
8444096 - 财政年份:2012
- 资助金额:
$ 37.05万 - 项目类别:
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car
MDM2/Bcl-2 在腺样囊肿临床前模型中的治疗性抑制
- 批准号:
8915672 - 财政年份:2012
- 资助金额:
$ 37.05万 - 项目类别:
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car
MDM2/Bcl-2 在腺样囊肿临床前模型中的治疗性抑制
- 批准号:
8537888 - 财政年份:2012
- 资助金额:
$ 37.05万 - 项目类别:
Therapeutic Inhibition of MDM2/Bcl-2 in Pre-clinical Models of Adenoid Cystic Car
MDM2/Bcl-2 在腺样囊肿临床前模型中的治疗性抑制
- 批准号:
8712454 - 财政年份:2012
- 资助金额:
$ 37.05万 - 项目类别:
Mechanisms of dental pulp stem cell differentiation into functional endothelium
牙髓干细胞分化为功能性内皮细胞的机制
- 批准号:
8485582 - 财政年份:2011
- 资助金额:
$ 37.05万 - 项目类别:
Perivascular niche for salivary gland cancer stem cells and resistance to therapy
唾液腺癌干细胞的血管周围生态位和治疗耐药性
- 批准号:
8402545 - 财政年份:2011
- 资助金额:
$ 37.05万 - 项目类别:
Perivascular niche for salivary gland cancer stem cells and resistance to therapy
唾液腺癌干细胞的血管周围生态位和治疗耐药性
- 批准号:
8603155 - 财政年份:2011
- 资助金额:
$ 37.05万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.05万 - 项目类别:
Research Grant














{{item.name}}会员




